Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes - PubMed (original) (raw)
Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes
J A Fletcher et al. Cancer Genet Cytogenet. 1994 Oct.
Abstract
Relatively few karyotypes have been reported from short-term cultures and/or direct harvests of osteosarcomas. We describe clonal aberrations in 17 high-grade osteosarcoma specimens and in one low-grade osteosarcoma. The high-grade osteosarcomas were karyotyped after direct harvest (four cases) or after short-term culture periods of < 1 week (13 cases). Three of these specimens, a primary osteosarcoma and two lung metastases, were from the same patient and shared a number of clonal aberrations. No consistent chromosome translocations were identified in the overall group of high-grade osteosarcomas, but potential nonrandom deletions involved 6q21-->qter, 9p21-->pter, chromosome 10, chromosome 13, 17p12-pter, and chromosome 20. Ring chromosomes were detected in three cases, and double-minute (dmin) chromosomes were detected in six. All high-grade osteosarcomas had numerous nonclonal chromosome aberrations superimposed on complex clonal events. The single low-grade osteosarcoma was characterized by a balanced, nonconstitutional, t(5;10) (p13;p14-15), together with an addition to the short arm of chromosome X. This is the first translocation reported in low-grade osteosarcoma, and the simplicity of the karyotype contrasts strikingly with those in the high-grade osteosarcomas.
Similar articles
- [Cytogenetic changes in low grade central osteosarcomas].
Werner M, Rieck J, Delling G. Werner M, et al. Verh Dtsch Ges Pathol. 1998;82:189-94. Verh Dtsch Ges Pathol. 1998. PMID: 10095432 German. - Chromosome analysis of nine osteosarcomas.
Hoogerwerf WA, Hawkins AL, Perlman EJ, Griffin CA. Hoogerwerf WA, et al. Genes Chromosomes Cancer. 1994 Feb;9(2):88-92. doi: 10.1002/gcc.2870090203. Genes Chromosomes Cancer. 1994. PMID: 7513549 - Cytogenetic findings in 19 malignant bone tumors.
Ozisik YY, Meloni AM, Peier A, Altungoz O, Spanier SS, Zalupski MM, Leong SP, Sandberg AA. Ozisik YY, et al. Cancer. 1994 Oct 15;74(8):2268-75. doi: 10.1002/1097-0142(19941015)74:8<2268::aid-cncr2820740810>3.0.co;2-5. Cancer. 1994. PMID: 7922978 - Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature.
Bridge JA, Nelson M, McComb E, McGuire MH, Rosenthal H, Vergara G, Maale GE, Spanier S, Neff JR. Bridge JA, et al. Cancer Genet Cytogenet. 1997 May;95(1):74-87. doi: 10.1016/s0165-4608(96)00306-8. Cancer Genet Cytogenet. 1997. PMID: 9140456 Review. - [The clonal evolution of osteosarcomas].
Baumhoer D. Baumhoer D. Pathologe. 2016 Nov;37(Suppl 2):163-168. doi: 10.1007/s00292-016-0200-x. Pathologe. 2016. PMID: 27651058 Review. German.
Cited by
- Genetically engineered mouse models and human osteosarcoma.
Ng AJ, Mutsaers AJ, Baker EK, Walkley CR. Ng AJ, et al. Clin Sarcoma Res. 2012 Oct 4;2(1):19. doi: 10.1186/2045-3329-2-19. Clin Sarcoma Res. 2012. PMID: 23036272 Free PMC article. - Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors.
Gisselsson D, Jonson T, Petersén A, Strömbeck B, Dal Cin P, Höglund M, Mitelman F, Mertens F, Mandahl N. Gisselsson D, et al. Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12683-8. doi: 10.1073/pnas.211357798. Epub 2001 Oct 2. Proc Natl Acad Sci U S A. 2001. PMID: 11675499 Free PMC article. - HACE1 is a potential tumor suppressor in osteosarcoma.
El-Naggar AM, Clarkson PW, Negri GL, Turgu B, Zhang F, Anglesio MS, Sorensen PH. El-Naggar AM, et al. Cell Death Dis. 2019 Jan 8;10(1):21. doi: 10.1038/s41419-018-1276-4. Cell Death Dis. 2019. PMID: 30622235 Free PMC article. - Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.
Huang SF, Xiao S, Renshaw AA, Loughlin KR, Hudson TJ, Fletcher JA. Huang SF, et al. Am J Pathol. 1996 Nov;149(5):1565-73. Am J Pathol. 1996. PMID: 8909246 Free PMC article. - Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma.
Sonaglio V, de Carvalho AC, Toledo SR, Salinas-Souza C, Carvalho AL, Petrilli AS, de Camargo B, Vettore AL. Sonaglio V, et al. Onco Targets Ther. 2013 Jun 17;6:713-23. doi: 10.2147/OTT.S44918. Print 2013. Onco Targets Ther. 2013. PMID: 23836983 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials